STARTUP PROFILE

Reach Neuro

COUNTRY
USA
FOUNDED
2021
CATEGORY
Neuromodulation
Developing implantable spinal cord stimulation systems (Avantis) that restore voluntary upper-limb movement in chronic stroke survivors.
Visit website →
Neurofounders Insights
$   Funding   -
Seed
MODALITY
SCS
FORM FACTOR
Implant
INTERFACE DEPTH
Implantable
INDICATION
Stroke
TARGET USER
Patients
REGULATORY STAGE
Investigational
Reach Neuro is developing implantable spinal cord stimulation systems specifically for upper-limb recovery after stroke, placing it in the restorative neurorehabilitation category. Its indication focus is distinctive, though proving durable motor benefit will be essential.
Mentioned in Market Notes
MOST RECENT COVERAGE
No items found.
Articles featuring
Reach Neuro
No items found.